Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes

被引：0
|
作者：
Savant, Deepika [1 ]
Vitkovski, Taisia [1 ]
Thomas, Rebecca [1 ]
Rishi, Arvind [1 ]
机构：
[1] Hofstra Northwell Hlth Sch Med, Lake Success, NY USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
799
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [1] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    MODERN PATHOLOGY, 2017, 30 : 199A - 199A
  • [2] Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance
    Mondal, Santosh Kumar
    Bhattacharya, Saptarshi
    Sarkar, Aditya Prasad
    Saha, Rama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S81 - S86
  • [3] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non -Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    MODERN PATHOLOGY, 2017, 30 : 475A - 475A
  • [4] Programmed cell death ligand-1 (PD-L1) expression in desmoid tumors: a retrospective study
    Yildirim, A. N. Toksoz
    Akyurek, M.
    Okay, E.
    Zenginkinet, T.
    Iyetin, Y.
    Ozkan, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (11) : 5223 - 5229
  • [5] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [6] TUMOR INFILTRATING LYMPHOCYTES AND PROGRAMMED DEATH LIGAND 1 (PD-L1) EXPRESSION IN DIFFUSE AND ANAPLASTIC GLIOMAS
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Wilhelm, D.
    Rajky, O.
    Kurscheid, S.
    Hegi, M.
    Woehrer, A.
    Marosi, C.
    Preusser, M.
    NEURO-ONCOLOGY, 2016, 18 : 26 - 26
  • [7] Programmed death ligand 1 (PD-L1) expression and tumor infiltrating lymphocytes in diffuse and anaplastic gliomas
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Rajky, O.
    Ricken, G.
    Woehrer, A.
    Dieckmann, K.
    Zielinski, C. C.
    Marosi, C.
    Preusser, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S593 - S593
  • [8] Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
    Feng, Yong
    Shen, Jacson
    Gao, Yan
    Liao, Yunfei
    Cote, Gregory
    Choy, Edwin
    Chebib, Ivan
    Mankin, Henry
    Hornicek, Francis
    Duan, Zhenfeng
    ONCOTARGET, 2015, 6 (13) : 11139 - 11149
  • [9] Prevalence of programmed death-1 ligand-1 (PD-L1) and infiltrating lymphocytes in human gastric carcinogenesis
    Liu, Zhonghua
    Wang, Yufang
    Luo, Xiaolei
    Wang, Yanyun
    Zhang, Lin
    Wang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11754 - 11759
  • [10] PROGRAMMED DEATH LIGAND-1 (PD-L1) EXPRESSION STATUS IN PENILE SQUAMOUS CELL CARCINOMA TUMOR CELLS AND TUMOR INFILTRATING IMMUNE CELLS
    Rider, Jennifer
    Harlow, Alyssa
    Giunchi, Francesca
    Carlsson, Jessica
    Kirrander, Peter
    Fiorentino, Michelangelo
    Andren, Ove
    Davidsson, Sabina
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1129 - E1130
12345